Goldman Sachs
PRCT icon

Goldman Sachs’s Procept Biorobotics PRCT Stock Holding History

Goldman Sachs’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.55M Sell
302,044
-215,688
-42% -$6.08M ﹤0.01% 3308
2025
Q4 		$16.3M Buy
517,732
+241,863
+88% +$8.02M ﹤0.01% 2576
2025
Q3 		$9.85M Sell
275,869
-74,651
-21% -$3.41M ﹤0.01% 2984
2025
Q2 		$20.2M Sell
350,520
-59,903
-15% -$3.39M ﹤0.01% 2117
2025
Q1 		$23.9M Sell
410,423
-139,892
-25% -$9.55M ﹤0.01% 1858
2024
Q4 		$44.3M Buy
550,315
+195,380
+55% +$16.7M 0.01% 1410
2024
Q3 		$28.4M Buy
354,935
+74,972
+27% +$5.33M ﹤0.01% 1738
2024
Q2 		$17.1M Buy
279,963
+130,846
+88% +$7.78M ﹤0.01% 2009
2024
Q1 		$7.37M Buy
149,117
+52,890
+55% +$2.52M ﹤0.01% 2758
2023
Q4 		$4.03M Buy
96,227
+5,365
+6% +$183K ﹤0.01% 3347
2023
Q3 		$2.98M Buy
90,862
+11,059
+14% +$377K ﹤0.01% 3437
2023
Q2 		$2.82M Sell
79,803
-84,821
-52% -$2.8M ﹤0.01% 3605
2023
Q1 		$4.68M Buy
164,624
+38,002
+30% +$1.34M ﹤0.01% 3124
2022
Q4 		$5.26M Buy
126,622
+57,379
+83% +$2.46M ﹤0.01% 3119
2022
Q3 		$2.87M Buy
69,243
+53,973
+353% +$2.15M ﹤0.01% 3645
2022
Q2 		$499K Buy
15,270
+4,566
+43% +$166K ﹤0.01% 5076
2022
Q1 		$375K Buy
+10,704
New +$258K ﹤0.01% 5520
2021
Q4 		– Sell
-57,803
Closed -$2.21M – 6648
2021
Q3 		$2.21M Buy
+57,803
New +$2.22M ﹤0.01% 4108

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs's PRCT Position: Q1 2026 in Review

Goldman Sachs reduced its Procept Biorobotics (PRCT) stake by 42% in Q1 2026, selling an estimated $6.08M and leaving 302,044 shares worth $7.55M. The position accounts for ﹤0.01% of the portfolio, ranked #3308.

Goldman Sachs first reported a position in PRCT in Q3 2021 and has held it in 18 quarters since. The position peaked at $44.3M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Goldman Sachs held 302,044 shares of Procept Biorobotics worth $7.55M as of Q1 2026.
  • Goldman Sachs sold 215,688 Procept Biorobotics shares in Q1 2026, an estimated $6.08M.
  • Procept Biorobotics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3308 holding.
  • Goldman Sachs first reported a position in Procept Biorobotics in Q3 2021 and has held it in 18 quarters since.
  • Goldman Sachs's Procept Biorobotics position peaked at $44.3M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.